Peapack-Gladstone Financial Corp’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $384K | Sell |
8,995
-17,010
| -65% | -$760K | ﹤0.01% | 551 |
|
|
2026
Q1 | $1.25M | Sell |
26,005
-594
| -2% | -$27.7K | 0.02% | 386 |
|
|
2025
Q4 | $1.29M | Sell |
26,599
-1,227
| -4% | -$60.8K | 0.02% | 379 |
|
|
2025
Q3 | $1.31M | Buy |
27,826
+4,447
| +19% | +$215K | 0.02% | 381 |
|
|
2025
Q2 | $1.13M | Sell |
23,379
-924
| -4% | -$47.2K | 0.02% | 387 |
|
|
2025
Q1 | $1.35M | Sell |
24,303
-1,684
| -6% | -$91.2K | 0.02% | 372 |
|
|
2024
Q4 | $1.25M | Sell |
25,987
-183
| -0.7% | -$9.3K | 0.02% | 372 |
|
|
2024
Q3 | $1.51M | Hold |
26,170
| – | – | 0.02% | 359 |
|
|
2024
Q2 | $1.27M | Hold |
26,170
| – | – | 0.02% | 370 |
|
|
2024
Q1 | $1.27M | Sell |
26,170
-1,354
| -5% | -$66.1K | 0.02% | 374 |
|
|
2023
Q4 | $1.37M | Buy |
27,524
+10,641
| +63% | +$520K | 0.02% | 361 |
|
|
2023
Q3 | $906K | Buy |
16,883
+310
| +2% | +$16.5K | 0.02% | 397 |
|
|
2023
Q2 | $892K | Sell |
16,573
-4,594
| -22% | -$247K | 0.02% | 409 |
|
|
2023
Q1 | $1.15M | Sell |
21,167
-659
| -3% | -$32.1K | 0.02% | 367 |
|
|
2022
Q4 | $1.06M | Sell |
21,826
-5,555
| -20% | -$244K | 0.02% | 362 |
|
|
2022
Q3 | $1.04M | Sell |
27,381
-7,906
| -22% | -$352K | 0.02% | 362 |
|
|
2022
Q2 | $1.77M | Buy |
35,287
+1,319
| +4% | +$70K | 0.04% | 284 |
|
|
2022
Q1 | $1.75M | Buy |
33,968
+815
| +2% | +$42.1K | 0.03% | 306 |
|
|
2021
Q4 | $1.66M | Buy |
33,153
+5,054
| +18% | +$250K | 0.03% | 307 |
|
|
2021
Q3 | $1.36M | Buy |
28,099
+12,968
| +86% | +$659K | 0.03% | 324 |
|
|
2021
Q2 | $797K | Buy |
15,131
+3,101
| +26% | +$162K | 0.02% | 372 |
|
|
2021
Q1 | $596K | Buy |
+12,030
| New | +$578K | 0.02% | 387 |
|
|
2020
Q4 | – | Sell |
-4,450
| Closed | -$223K | – | 438 |
|
|
2020
Q3 | $223K | Sell |
4,450
-117
| -3% | -$6.02K | 0.01% | 348 |
|
|
2020
Q2 | $233K | Sell |
4,567
-41
| -0.9% | -$1.99K | 0.01% | 344 |
|
|
2020
Q1 | $201K | Buy |
4,608
+394
| +9% | +$18.9K | 0.01% | 346 |
|
|
2019
Q4 | $212K | Buy |
+4,214
| New | +$197K | 0.01% | 339 |
|
|
2019
Q3 | – | Sell |
-14,237
| Closed | -$616K | – | 362 |
|
|
2019
Q2 | $616K | Buy |
+14,237
| New | +$605K | 0.03% | 245 |
|
|
2015
Q4 | – | Sell |
-4,234
| Closed | -$201K | – | 339 |
|
|
2015
Q3 | $201K | Hold |
4,234
| – | – | 0.02% | 313 |
|
|
2015
Q2 | $210K | Hold |
4,234
| – | – | 0.01% | 305 |
|
|
2015
Q1 | $209K | Buy |
+4,234
| New | +$202K | 0.01% | 312 |
|
Other funds holding SNY
MIP
BIP
Peapack-Gladstone Financial Corp's SNY Position: Q2 2026 in Review
Peapack-Gladstone Financial Corp reduced its Sanofi (SNY) stake by 65% in Q2 2026, selling an estimated $760K and leaving 8,995 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #551.
Peapack-Gladstone Financial Corp first reported a position in SNY in Q1 2015 and has held it in 30 quarters since. The position peaked at $1.77M in Q2 2022. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Peapack-Gladstone Financial Corp held 8,995 shares of Sanofi worth $384K as of Q2 2026.
- Peapack-Gladstone Financial Corp sold 17,010 Sanofi shares in Q2 2026, an estimated $760K.
- Sanofi made up ﹤0.01% of Peapack-Gladstone Financial Corp's portfolio in Q2 2026, its #551 holding.
- Peapack-Gladstone Financial Corp first reported a position in Sanofi in Q1 2015 and has held it in 30 quarters since.
- Peapack-Gladstone Financial Corp's Sanofi position peaked at $1.77M in Q2 2022.
- 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2026, filed 14 Aug 2026.